Clinical Trial Update: Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies [Phase 2]

View source ↗

Summary

This update describes a Phase 2 pilot trial evaluating allogeneic blood or marrow transplantation for primary immunodeficiency disorders, with recruitment ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Lymphoproliferative Syndrome
• Common Variable Immunodeficiency
• Lymphoproliferative Disorders
• T-cell Immunodeficiency Disorders

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency | Phase 2 | Status: RECRUITING